We consider ResMed not too risky. ResMed maintains Sharpe Ratio (i.e. Efficiency) of 0.1052 which implies ResMed had 0.1052% of return per unit of risk over the last 2 months. Our philosophy towards forecasting volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for ResMed which you can use to evaluate future volatility of the company. Please check ResMed Coefficient Of Variation of 989.36, Semi Deviation of 1.07 and Risk Adjusted Performance of 0.166 to confirm if risk estimate we provide are consistent with the epected return of 0.1319%.
|Time Horizon||30 Days Login to change|
ResMed Market Sensitivity
|As returns on market increase, ResMed returns are expected to increase less than the market. However during bear market, the loss on holding ResMed will be expected to be smaller as well.2 Months Beta |Analyze ResMed Demand TrendCheck current 30 days ResMed correlation with market (DOW)|
β = 0.1551
ResMed Technical Analysis
Projected Return Density Against MarketConsidering 30-days investment horizon, ResMed has beta of 0.1551 . This implies as returns on market go up, ResMed average returns are expected to increase less than the benchmark. However during bear market, the loss on holding ResMed will be expected to be much smaller as well. Moreover, ResMed has an alpha of 0.1304 implying that it can potentially generate 0.1304% excess return over DOW after adjusting for the inherited market risk (beta).
Predicted Return Density